BDX vs Peers Stock Comparison

Becton Dickinson Prices as of Oct 26, 2026 Peers: Industry group
BDX Becton Dickinson & Co
$196.39 +6.8% 1M +5.7% 1Y
Market cap
$53.66B
P/E
57.0x
Revenue (TTM)
$23.25B
Div. yield
–
Medical Supplies Healthcare

Percentile Scorecard

BDX

Each axis is the mean percentile of its metrics against the company's industry group. 100 is the best in the group, 50 the middle.

Scores by Axis

AxisBDX
Valuation 90 #24 of 228
Growth 47 #117 of 221
Profitability 78 #46 of 208
Financial Health 27 #176 of 239
Shareholder Returns 95 #8 of 137
Overall 67
  • BDX ranked among 248 companies in Medical Devices and Diagnostics

Price Performance

Price return, split-adjusted, before dividends. Click a name to hide or show it.

Returns

PeriodBDXSPY
1 month +6.8% -0.8%
3 months +23.6% +3.5%
6 months +30.7% +7.0%
Year to date +1.2% +12.2%
1 year +5.7% +13.0%
3 years -21.9% +86.3%
3 years, per year -7.9% +23.1%
5 years -19.8% +68.6%
5 years, per year -4.3% +11.0%
10 years +17.2% +258.0%
10 years, per year +1.6% +13.6%

Risk

MeasureBDXSPY
Volatility, 1Y 31.9% 12.7%
Downside volatility, 1Y 33.1% 12.7%
Beta vs S&P 500, 1Y 0.34 1.00
Return / volatility, 1Y 0.18 1.02
Max drawdown, 5Y -50.4% -25.4%
From 52-week high -6.5% -1.8%
52-week high $210.02 $779.14
52-week low $140.71 $631.97

Valuation History

Weekly multiples on trailing twelve-month fundamentals. Negative or extreme readings (a loss year, a collapsed denominator) are left out so the chart stays readable.

MultipleBDX
P/E now vs peer median 57.3xmedian 30.6x
P/S now vs peer median 2.3xmedian 3.0x
EV/EBITDA now vs peer median 14.0xmedian 17.5x
P/FCF now vs peer median 16.7xmedian 23.3x
P/B now vs peer median 2.2xmedian 2.4x
PEG now vs peer median -3.93median 0.87

Financial History

Reported figures by fiscal period, placed on the calendar year (or quarter) each period ended in, so companies with different fiscal years line up.

Trailing twelve monthsBDX
Revenue $23.25B
Gross profit $10.91B
Operating income $2.48B
Net income $941.00M
Free cash flow $3.20B
R&D $1.37B
EPS (diluted) $3.42
Cash & equivalents $708.00M
Total debt $72.81B
Shares (diluted) 275.16M
Enterprise value $50.80B

All Metrics

58 metrics · best in bold

Bold marks the best reading: the lowest positive value for multiples, leverage and payout, the highest for everything else. The bar under each value is its percentile against that company's own peers. Hover a value for its rank and the peer median.

Valuation

12 metrics
MetricBDX
P/E 57.3x
P/FCF 16.7x
P/Operating cash flow 13.5x
P/S 2.3x
P/B 2.2x
P/Tangible book 2.2x
EV/EBITDA 14.0x
EV/EBIT 28.0x
EV/Revenue 3.0x
EV/FCF 21.7x
EV/Operating cash flow 17.6x
PEG (3Y EPS CAGR) -3.93

Growth

14 metrics
MetricBDX
Revenue growth (1Y) 17.4%
Revenue CAGR (3Y) 6.9%
Gross profit growth (1Y) 23.7%
Gross profit CAGR (3Y) 8.5%
Operating income growth (1Y) 13.0%
Operating income CAGR (3Y) 3.3%
Net income growth (1Y) -40.6%
Net income CAGR (3Y) -17.3%
EPS growth (1Y) -38.0%
EPS CAGR (3Y) -14.6%
Operating cash flow growth (1Y) 43.5%
Operating cash flow CAGR (3Y) 14.5%
Free cash flow growth (1Y) 54.2%
Free cash flow CAGR (3Y) 22.5%

Profitability

14 metrics
MetricBDX
Gross margin 46.9%
EBITDA margin 21.4%
Operating margin 10.7%
Pretax margin 8.4%
Net margin 4.0%
FCF margin 13.8%
Operating cash flow margin 17.0%
Return on equity 3.9%
Return on assets 1.9%
Return on invested capital 5.3%
Return on capital employed 6.0%
Asset turnover 0.5x
Cash conversion (OCF / net income) 4.2x
Stock comp / revenue 1.2%

Financial Health

11 metrics
MetricBDX
Debt / assets 33.1%
Debt / equity 0.7x
Net debt / EBITDA 3.2x
Debt / FCF 5.2x
Liabilities / assets 51.9%
Equity / assets 48.1%
Interest coverage 4.2x
Current ratio 0.9x
Quick ratio 0.3x
Cash ratio 0.1x
Altman Z-score 2.29

Shareholder Returns

7 metrics
MetricBDX
Dividend yield 2.1%
Net buyback yield 4.7%
Shareholder yield 6.8%
Payout ratio (earnings) –
Payout ratio (FCF) –
Dividend growth (1Y) –
Dividend CAGR (3Y) –

Analyst Estimates

Solid lines are reported fiscal-year results; dashed lines are the consensus for the years ahead. Hover a year for the analysts' high and low, and how each result compared with its estimate.

ConsensusBDX
Forward P/E 15.1xFY2026
EPS, next fiscal year $12.99FY2026
EPS growth, next FY +14.8%FY2026
EPS growth, the year after -2.9%
Revenue, next fiscal year $18.11BFY2026
Revenue growth, next FY -17.1%FY2026
Revenue growth, the year after +11.6%

Institutional Ownership

13F filings, quarter ended Jun 30, 2026
HoldersBDX
Held by institutions 96.1%
Institutions holding 1,442
Change in shares held, QoQ +0.6%
Institutions buying 688
Institutions selling 543
Buyers to sellers 1.27

Add a Peer

Largest companies in the same industry

Related Comparisons

Data from SEC filings, exchange prices and consensus estimates, via Business Quant. Percentile scores compare each company with its own peer group, so two companies' scores are each relative to different peers unless you rank against the whole market. Price returns exclude dividends. Nothing on this page is investment advice.